This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

AlerisLife Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

63.8%

Wachstumsrate der Gewinne

64.0%

EPS-Wachstumsrate

Healthcare Gewinnwachstum	20.9%
Wachstumsrate der Einnahmen	68.9%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	20 Mar 2023

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Analysts Are Optimistic We'll See A Profit From Five Star Senior Living Inc. (NASDAQ:FVE)

Mar 14

What Is The Ownership Structure Like For Five Star Senior Living Inc. (NASDAQ:FVE)?

Feb 16

Five Star Senior Living's (NASDAQ:FVE) Shareholders Are Down 71% On Their Shares

Jan 29

Is Five Star Senior Living (NASDAQ:FVE) Using Too Much Debt?

Jan 12

Should You Think About Buying Five Star Senior Living Inc. (NASDAQ:FVE) Now?

Dec 25

Five Star Senior Living: Additional Upside Looks Probable

Dec 16

Has Five Star Senior Living Inc.'s (NASDAQ:FVE) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Dec 07

Are Five Star Senior Living's (NASDAQ:FVE) Statutory Earnings A Good Guide To Its Underlying Profitability?

Nov 19

Five Star Senior Living Inc. 2020 Q3 - Results - Earnings Call Presentation

Nov 08

Gewinn- und Umsatzwachstumsprognosen

NasdaqCM:ALR - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2023	789	-15	N/A	-4	1
12/31/2022	713	-34	N/A	-47	1
9/30/2022	160	-38	-69	-54	N/A
6/30/2022	161	-39	-78	-64	N/A
3/31/2022	168	-43	-81	-68	N/A
12/31/2021	180	-30	-17	-8	N/A
9/30/2021	193	-16	-18	-9	N/A
6/30/2021	205	-2	22	29	N/A
3/31/2021	213	13	67	73	N/A
12/31/2020	222	-8	46	51	N/A
9/30/2020	437	6	22	46	N/A
6/30/2020	656	-5	-6	31	N/A
3/31/2020	880	-4	-54	-7	N/A
12/31/2019	1,101	-20	-62	-4	N/A
9/30/2019	1,114	-60	-66	-16	N/A
6/30/2019	1,116	-74	-75	-25	N/A
3/31/2019	1,112	-99	-85	-34	N/A
12/31/2018	1,110	-74	-103	-54	N/A
9/30/2018	1,112	-51	-88	-35	N/A
6/30/2018	1,119	-36	-75	-19	N/A
3/31/2018	1,128	-22	-65	-3	N/A
12/31/2017	1,136	-21	-54	17	N/A
9/30/2017	1,138	-26	-60	10	N/A
6/30/2017	1,137	-25	-74	-8	N/A
3/31/2017	1,139	-26	-71	-11	N/A
12/31/2016	1,136	-22	-79	-23	N/A
9/30/2016	1,135	-22	-60	-3	N/A
6/30/2016	1,135	-43	N/A	12	N/A
3/31/2016	1,130	-38	N/A	18	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: ALR wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: ALR wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: ALR wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: ALRDie Einnahmen des Unternehmens (68.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.9% pro Jahr).

Hohe Wachstumseinnahmen: ALRDie Einnahmen des Unternehmens (68.9% pro Jahr) werden voraussichtlich schneller wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von ALR in 3 Jahren voraussichtlich hoch sein wird

This company listing is no longer active

AlerisLife Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target decreased to US$1.50

No longer forecast to breakeven

No longer forecast to breakeven

Consensus forecasts updated

Forecast breakeven date pushed back to 2024

Consensus EPS estimates fall by 144%

Recent updates

Chairman & MD recently bought US$29m worth of stock

Insufficient new directors

ABP Acquisition LLC entered into an agreement to acquire the remaining 93.7% stake in AlerisLife Inc. (NasdaqCM:ALR) from Diversified Healthcare Trust (NasdaqGS:DHC) and others for $41.2 million.

Price target decreased to US$1.50

AlerisLife Inc. Receives a Notification Letter from Nasdaq Regarding Minimum Bid Price

No longer forecast to breakeven

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Alerislife Inc. Appoints Philip Benjamson as Senior Vice President and Chief Operating Officer

AlerisLife names new operations chief

AlerisLife Inc. to Report Q3, 2022 Results on Nov 02, 2022

AlerisLife Inc. Announces Chief Financial Officer Changes

AlerisLife appoints Heather Pereira as senior VP, CFO and Treasurer

No longer forecast to breakeven

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

AlerisLife Inc. to Report Q2, 2022 Results on Aug 03, 2022

Consensus forecasts updated

First quarter 2022 earnings: EPS and revenues miss analyst expectations

AlerisLife Inc. Announces Management Changes

Forecast breakeven date pushed back to 2024

AlerisLife Inc., Annual General Meeting, Jun 07, 2022

Consensus EPS estimates fall by 144%

Forecast breakeven date pushed back to 2024

AlerisLife Inc. to Report Q1, 2022 Results on May 03, 2022

Consensus forecasts updated

Insider recently bought US$101k worth of stock

Is AlerisLife (NASDAQ:ALR) Using Too Much Debt?

AlerisLife Still Needs To Execute Despite Wall Street Bullishness

Price target decreased to US$5.50

Full year 2021 earnings: EPS exceeds analyst expectations

AlerisLife Inc. to Report Q4, 2021 Results on Feb 23, 2022

Third quarter 2021 earnings released: US$0.32 loss per share (vs US$0.12 profit in 3Q 2020)

Five Star: A Professional Opportunity For The Retail Investor

Five Star Senior Living: The $3.80 Level Most Likely The Bottom

Consensus forecasts updated

Price target decreased to US$6.75

Second quarter 2021 earnings released: US$0.39 loss per share (vs US$0.095 profit in 2Q 2020)

Forecast breakeven pushed back to 2022

Investor sentiment deteriorated over the past week

Five Star Senior Living: Buy Your Winter Coats In Summer

Five Star Senior Living Inc.(NasdaqCM:FVE) dropped from Russell 3000E Value Index

Investor sentiment improved over the past week

Is Now The Time To Look At Buying Five Star Senior Living Inc. (NASDAQ:FVE)?

First quarter 2021 earnings released: EPS US$0.10 (vs US$0.55 loss in 1Q 2020)

Five Star Senior Living Inc. 2021 Q1 - Results - Earnings Call Presentation

Five Star Senior Living (NASDAQ:FVE) Seems To Use Debt Quite Sensibly

Analysts Are Optimistic We'll See A Profit From Five Star Senior Living Inc. (NASDAQ:FVE)

New 90-day low: US$6.19

Chief Accounting Officer has left the company

Full year 2020 earnings released: US$0.24 loss per share (vs US$3.99 loss in FY 2019)

Revenue and earnings miss expectations

What Is The Ownership Structure Like For Five Star Senior Living Inc. (NASDAQ:FVE)?

Investor sentiment improved over the past week

New 90-day high: US$8.66

Five Star Senior Living Inc. Partners with CVS to Administer Vaccines to Shop Community Residents and Staff, Which Commenced in December 2020

Five Star Senior Living's (NASDAQ:FVE) Shareholders Are Down 71% On Their Shares

Five Star Senior Living Inc. to Report Q4, 2020 Results on Feb 24, 2021

Is Five Star Senior Living (NASDAQ:FVE) Using Too Much Debt?

Should You Think About Buying Five Star Senior Living Inc. (NASDAQ:FVE) Now?

Five Star Senior Living: Additional Upside Looks Probable

New 90-day high: US$7.44

Has Five Star Senior Living Inc.'s (NASDAQ:FVE) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Market bids up stock over the past week

Market bids up stock over the past week

New 90-day high: US$5.68

Are Five Star Senior Living's (NASDAQ:FVE) Statutory Earnings A Good Guide To Its Underlying Profitability?

Five Star Senior Living Inc. 2020 Q3 - Results - Earnings Call Presentation

Third quarter 2020 earnings released: EPS US$0.12

New 90-day low: US$4.49